首页> 外文期刊>Ciencia Rural >Use of metaphylactic protocols based on the risk to develop bovine respiratory diseases in feedlot cattle.
【24h】

Use of metaphylactic protocols based on the risk to develop bovine respiratory diseases in feedlot cattle.

机译:根据在饲养场牛中发生牛呼吸系统疾病的风险使用代谢方案。

获取原文
       

摘要

Bovine respiratory diseases (BRD) affect production rates negatively because it compromise health and well-being of the affected animal. The hypothesis of this study was that the use of metaphylactic protocols based on the risk to develop BRD would reduce morbidity and pulmonary lesions. For this purpose, the aims of this study were to evaluate the effect of two metaphylactic protocols on the morbidity of feedlot cattle with a known sanitary history, occurrence of pulmonary lesions at slaughter, and the possible participation of Mannheimia haemolytica, Histophilus somni, Bovine alphaherpesvirus 1 (BoHV-1) and bovine respiratory syncytial virus (BRSV) in the development of BRD. An experimental study was designed in which 3,094 adult, male, cattle, were grouped according to the risk to develop BRD: a) group without metaphylaxis (n=2,104), low-risk animals; b) metaphylaxis group with oxytetracycline (n=789), moderate-risk animals; c) metaphylaxis group with tildipirosin (n=201), high-risk animals. All cattle were immunized against pathogens associated with BRD (BoHV-1, BVDV, BRSV, PI3). The morbidity for BRD was 8.2% (253/3,094); cattle within the moderate-risk group for BRD had the lowest frequency (6.1%), followed by high-risk animals with tildipirosin metaphylaxis (6.5%) and low-risk without metaphylaxis (9.1%) (P=0.019). At the abattoir, 1.2% of lungs with lesions were found. There was a difference (P=0.036) in the frequency of pulmonary lesions between healthy animals (1.1%) and those diagnosed with BRD (2.8%). Two agents associated with BRD were identified by PCR assays in the lungs (n=37) of cattle: M. haemolytica (16.2%) and H. somni (5.4%). In addition, concomitant infections involving these pathogens were identified in the lungs of two steers. These results demonstrate that the use of metaphylactic protocols, based on the risk to develop BRD, reduces morbidity and pulmonary lesions in affected cattle. Furthermore, pulmonary lesions were more frequent in animals with a history of BRD.
机译:牛呼吸道疾病(BRD)会对生产率产生负面影响,因为它损害了患病动物的健康和福祉。这项研究的假设是,基于发生BRD的风险而采用的代谢方案可以减少发病率和肺部病变。为此,本研究的目的是评估两种代谢方案对已知卫生史的育肥牛的发病率,屠宰时发生肺部病变以及溶血曼海姆氏菌,嗜血性嗜血杆菌,牛α疱疹病毒的可能参与的影响。 1(BoHV-1)和牛呼吸道合胞病毒(BRSV)在BRD的发展中。设计了一项实验研究,其中根据发展BRD的风险将3,094头成年雄性牛分为一组:a)无代谢的组(n = 2,104),低风险的动物; b)羟四环素(n = 789)的中度风险动物的预防组; c)与替地吡辛(n = 201)的高风险动物的代谢治疗组。所有牛都针对与BRD相关的病原体(BoHV-1,BVDV,BRSV,PI3)进行了免疫。 BRD的发病率为8.2%(253 / 3,094);中度BRD风险组中的牛发生频率最低(6.1%),其次是具有tildipirosin代谢性的高风险动物(6.5%)和没有代谢性的低风险(9.1%)(P = 0.019)。在屠宰场,发现有病变的肺占1.2%。健康动物(1.1%)和确诊为BRD的动物(2.8%)之间的肺部病变频率存在差异(P = 0.036)。通过PCR分析在牛的肺部(n = 37)中鉴定了两种与BRD相关的药物:溶血支原体(16.2%)和索姆氏菌(5.4%)。此外,在两个ste牛的肺中发现了涉及这些病原体的伴随感染。这些结果表明,基于发展BRD的风险,采用代谢方案可减少患病牛的发病率和肺部病变。此外,具有BRD病史的动物的肺部病变更为常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号